These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24315301)

  • 1. Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy.
    Abelson B; Reddy CA; Ciezki JP; Angermeier K; Ulchaker J; Klein EA; Wood HM
    Urology; 2014 Feb; 83(2):422-7. PubMed ID: 24315301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of continence following 532 nm laser prostatectomy for patients previously treated with radiation therapy or brachytherapy.
    No D; Osterberg EC; Otto B; Naftali I; Choi B
    Lasers Surg Med; 2013 Aug; 45(6):358-61. PubMed ID: 23813669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters.
    Mock S; Leapman M; Stock RG; Hall SJ; Stone NN
    J Urol; 2013 Nov; 190(5):1805-10. PubMed ID: 23669568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.
    Kollmeier MA; Stock RG; Cesaretti J; Stone NN
    J Urol; 2005 Mar; 173(3):808-12. PubMed ID: 15711274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up.
    Bouchier-Hayes DM; Van Appledorn S; Bugeja P; Crowe H; Challacombe B; Costello AJ
    BJU Int; 2010 Apr; 105(7):964-9. PubMed ID: 19912196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy.
    Sarosdy MF
    Cancer; 2004 Aug; 101(4):754-60. PubMed ID: 15305406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic dose-feedback prostate brachytherapy in patients with large prostates and/or planned transurethral surgery before implantation.
    Acher PL; Popert R; Morris SL; Potters L; Austin-Smith SL; Johnson UH; Nichol JE; Beaney RP
    BJU Int; 2007 May; 99(5):1066-71. PubMed ID: 17233801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the risk of postoperative infection between transurethral vaporesection and transurethral resection of the prostate.
    May A; Broggi E; Lorphelin H; Tabchouri N; Giretti G; Pereira H; Bruyere F
    Lasers Surg Med; 2014 Jul; 46(5):405-11. PubMed ID: 24665004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
    Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
    BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of 120 W laser photoselective vaporization versus transurethral resection of the prostate for bladder outlet obstruction by prostate cancer.
    Altay B; Erkurt B; Kiremit MC; Horuz R; Guzelburc V; Albayrak S
    Urol Int; 2015; 94(3):326-9. PubMed ID: 25721931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial.
    Lukacs B; Loeffler J; Bruyère F; Blanchet P; Gelet A; Coloby P; De la Taille A; Lemaire P; Baron JC; Cornu JN; Aout M; Rousseau H; Vicaut E;
    Eur Urol; 2012 Jun; 61(6):1165-73. PubMed ID: 22341632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Nomura H; Seki N; Yamaguchi A; Naito S
    Int J Urol; 2009 Aug; 16(8):657-62. PubMed ID: 19602003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can high-dose-rate brachytherapy prevent the major genitourinary complication better than external beam radiation alone for patients with previous transurethral resection of prostate?
    Luo HL; Fang FM; Kang CH; Chuang YC; Chiang PH
    Int Urol Nephrol; 2013 Feb; 45(1):113-9. PubMed ID: 22972569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.